EPHB2 and cancer: To assess the possible contributions of EphB2 to the prognosis of cancer patients, we determined the relationship of EphB2 expression with survival, using the KMPLOT clinical microarray database, designed for meta-analysis-based biomarker assessment [28], and which includes 4142 patients with a follow-up of 69/40/49/33 months.